Patents by Inventor Teruo Nishida
Teruo Nishida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12339046Abstract: A heat pump device comprises a refrigerant circuit in which a compressor, a first indoor heat exchanger, an electric expansion valve, and a heat source-side heat exchanger are connected in a loop, a second indoor heat exchanger arranged between the compressor and the electric expansion valve and configured to store refrigerant during positive cycle defrost operation, an electromagnetic valve arranged between the second indoor heat exchanger and the electric expansion valve and configured to adjust an amount of refrigerant stored in the second indoor heat exchanger during the positive cycle defrost operation, and a control device that controls the compressor and the electric expansion valve.Type: GrantFiled: July 29, 2019Date of Patent: June 24, 2025Assignee: DAIKIN INDUSTRIES, LTD.Inventors: Yukio Matsusaka, Teruo Nishida, Kento Okuzawa
-
Publication number: 20230194117Abstract: An air conditioning ventilation system includes an air conditioner, a ventilator, and a control unit. The control unit controls operations of the air conditioner and the ventilator. The control unit causes the air conditioner to perform a compensation operation in order to compensate for a change in at least one of indoor temperature and humidity due to a ventilation operation prior to the ventilation operation to be performed by the ventilator.Type: ApplicationFiled: February 13, 2023Publication date: June 22, 2023Inventors: Tomoharu ASHIZAWA, Teruo NISHIDA
-
Publication number: 20220268460Abstract: An air conditioning system sufficiently cleans an indoor heat exchanger by using moisture in indoor air even when a room is dry before operation. An air conditioning system includes an air conditioner having an indoor unit and an outdoor unit, a humidifier, and a controller. The indoor unit has an indoor heat exchanger and exchanges heat of the indoor air by passing the indoor air through the indoor heat exchanger. The humidifier supplies moisture to the room to increase a humidity in the room. The controller controls the indoor unit and the humidifier. In the cleaning mode, the controller controls the humidifier to raise the humidity in the room, and then controls the indoor unit to perform a cleaning motion of cleaning a surface of the indoor heat exchanger by generating dew condensation water on the surface of the indoor heat exchanger.Type: ApplicationFiled: March 1, 2022Publication date: August 25, 2022Applicant: DAIKIN INDUSTRIES, LTD.Inventors: Kouji UGAI, Teruo NISHIDA, Hiroshi ITOU
-
Publication number: 20210341192Abstract: A heat pump device comprises a refrigerant circuit in which a compressor, a first indoor heat exchanger, an electric expansion valve, and a heat source-side heat exchanger are connected in a loop, a second indoor heat exchanger arranged between the compressor and the electric expansion valve and configured to store refrigerant during positive cycle defrost operation, an electromagnetic valve arranged between the second indoor heat exchanger and the electric expansion valve and configured to adjust an amount of refrigerant stored in the second indoor heat exchanger during the positive cycle defrost operation, and a control device that controls the compressor and the electric expansion valve.Type: ApplicationFiled: July 29, 2019Publication date: November 4, 2021Applicant: DAIKIN INDUSTRIES, LTD.Inventors: Yukio MATSUSAKA, Teruo NISHIDA, Kento OKUZAWA
-
Patent number: 10371421Abstract: The oil level in a compressor is lowered upon activation of the compressor. A heat pump-type heating device of the present invention includes: a refrigerant circuit in which a compressor, a heat-source-side heat exchanger, a motor-operated valve, and a target-side heat exchanger are provided; and an outdoor fan which is provided for the heat-source-side heat exchanger. The target-side heat exchanger is capable of heating, by a refrigerant, fluid supplied from outside. The rotation number of the outdoor fan upon activation of the compressor when a difference between a temperature of the fluid supplied to the target-side heat exchanger and an outside temperature is equal to or larger than a predetermined temperature difference is smaller than the rotation number when the difference is smaller than the predetermined temperature difference.Type: GrantFiled: October 17, 2016Date of Patent: August 6, 2019Assignee: Daikin Industries, Ltd.Inventors: Teruo Nishida, Shinji Yoshikawa, Yukio Matsusaka
-
Publication number: 20180313586Abstract: The oil level in a compressor is lowered upon activation of the compressor. A heat pump-type heating device of the present invention includes: a refrigerant circuit in which a compressor, a heat-source-side heat exchanger, a motor-operated valve, and a target-side heat exchanger are provided; and an outdoor fan which is provided for the heat-source-side heat exchanger. The target-side heat exchanger is capable of heating, by a refrigerant, fluid supplied from outside. The rotation number of the outdoor fan upon activation of the compressor when a difference between a temperature of the fluid supplied to the target-side heat exchanger and an outside temperature is equal to or larger than a predetermined temperature difference is smaller than the rotation number when the difference is smaller than the predetermined temperature difference.Type: ApplicationFiled: October 17, 2016Publication date: November 1, 2018Applicant: DAIKIN INDUSTRIES, LTD.Inventors: Teruo NISHIDA, Shinji YOSHIKAWA, Yukio MATSUSAKA
-
Patent number: 9702587Abstract: A coil support member is attached to a coil inside a water storage vessel and includes multiple openings, insertion portions and a non-insertion portion. The openings are arranged in a lengthwise direction, and together with surrounding sites prevent contact between mutually adjacent loops of the tube of the coil and suppress contact between an inner surface of the water storage vessel and an outer surface of the coil. The insertion portions are formed between the openings and are inserted into an intra-coil space located radially inward of the outer surface of the coil. The non-insertion portion is positioned in an extra-coil space located radially outward of the outer surface of the coil. The insertion portions have insertion body portions preventing contact between mutually adjacent loops of the tube, and engagement portions contacting the tube from the intra-coil space and maintaining an inserted state of the insertion body portions.Type: GrantFiled: February 26, 2010Date of Patent: July 11, 2017Assignees: Daikin Industries, Ltd., Daikin Europe N.V.Inventors: Yuuichi Kita, Teruo Nishida, Mathieu Ghesquiere
-
Publication number: 20120312253Abstract: A coil support member is attached to a coil inside a water storage vessel and includes multiple openings, insertion portions and a non-insertion portion. The openings are arranged in a lengthwise direction, and together with surrounding sites prevent contact between mutually adjacent loops of the tube of the coil and suppress contact between an inner surface of the water storage vessel and an outer surface of the coil. The insertion portions are formed between the openings and are inserted into an intra-coil space located radially inward of the outer surface of the coil. The non-insertion portion is positioned in an extra-coil space located radially outward of the outer surface of the coil. The insertion portions have insertion body portions preventing contact between mutually adjacent loops of the tube, and engagement portions contacting the tube from the intra-coil space and maintaining an inserted state of the insertion body portions.Type: ApplicationFiled: February 26, 2010Publication date: December 13, 2012Applicants: DAIKIN EUROPE N.V., DAIKIN INDUSTRIES, LTD.Inventors: Yuuichi Kita, Teruo Nishida, Mathieu Ghesquiere
-
Publication number: 20120225817Abstract: The present invention provides a therapeutic agent and a prophylactic agent for a gastrointestinal disease. A peptide having an amino acid sequence represented by Ser-Ser-Ser-Arg or a pharmaceutically acceptable salt thereof promotes wound healing in a gastrointestinal mucosal tissue, and is therefore useful as a therapeutic agent or a prophylactic agent for a gastrointestinal disease. Further, when (a) a peptide having an amino acid sequence represented by Ser-Ser-Ser-Arg or a pharmaceutically acceptable salt thereof and (b) a peptide having an amino acid sequence represented by Phe-Gly-Leu-Met-NH2 or a pharmaceutically acceptable salt thereof are administered in combination, these medicaments act synergistically and can significantly promote wound healing in a gastrointestinal mucosal tissue.Type: ApplicationFiled: November 10, 2010Publication date: September 6, 2012Applicants: Santen Pharmaceutical Co., Ltd., Yamaguchi UniversityInventors: Teruo Nishida, Makoto Inui, Kenji Matsuura, Masatsugu Nakamura, Takashi Nagano
-
Patent number: 8207119Abstract: An object is to find the minimum activity expression site of fibronectin, clarify the actions of this minimum unit in relation to opthalmological fields, and provide an opthalmological composition having this minimum unit as an effective component. This invention provides an opthalmological composition, in particular, a corneal disorder treatment agent containing the peptide, PHSRN (SEQ ID NO: 1) (Pro-His-Ser-Arg-Asn (SEQ ID NO: 1)), or Ac-Pro-His-Ser-Arg-Asn-NH2, which is a derivative thereof, or a salt thereof that is allowable as a medical drug as an effective component. The preferred dosage form is an ophthalmic formulation.Type: GrantFiled: September 15, 2009Date of Patent: June 26, 2012Assignee: Nihon Tenganyaku Kenkyusho Co., Ltd.Inventors: Teruo Nishida, Yorihisa Uetake, Hiroaki Iwata
-
Patent number: 8183343Abstract: A therapeutic method for treating a skin wound involving administering to a patient in need thereof a composition containing pharmaceutically effective amounts of the following components: (1) a peptide consisting of the amino acid sequence represented by Ser-Ser-Ser-Arg (SEQ ID NO: 1) or pharmaceutically acceptable salts thereof and (2) a peptide consisting of the amino acid sequence represented by Phe-Gly-Leu-Met-NH2 (SEQ ID NO: 2) or substance P or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable additive.Type: GrantFiled: July 29, 2010Date of Patent: May 22, 2012Assignees: Santen Pharmaceutical Co., Ltd.Inventors: Teruo Nishida, Makoto Inui, Masatsugu Nakamura
-
Publication number: 20110059897Abstract: A therapeutic method for treating a skin wound involving administering to a patient in need thereof a composition containing pharmaceutically effective amounts of the following components: (1) a peptide consisting of the amino acid sequence represented by Ser-Ser-Ser-Arg (SEQ ID NO: 1) or pharmaceutically acceptable salts thereof and (2) a peptide consisting of the amino acid sequence represented by Phe-Gly-Leu-Met-NH2 (SEQ ID NO: 2) or substance P or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable additive.Type: ApplicationFiled: July 29, 2010Publication date: March 10, 2011Applicants: SANTEN PHARMACEUTICAL CO., LTD.Inventors: Teruo Nishida, Makoto Inui, Masatsugu Nakamura
-
Patent number: 7795222Abstract: A method for treating a corneal disorder or for promoting skin wound healing comprising administering to a patient in need thereof a composition containing pharmaceutically effective amounts of (i) a first peptide comprising an amino acid sequence containing the following consecutive amino acids: Ser-Ser-Ser-Arg (SEQ ID NO: 1), or an analog thereof or a pharmaceutically acceptable salt thereof and (ii) a second peptide comprising an amino acid sequence containing the following consecutive amino acids with a terminal —NH2 group: Phe-Gly-Leu-Met-NH2 (SEQ ID NO: 2), or an analog thereof or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.Type: GrantFiled: March 20, 2007Date of Patent: September 14, 2010Assignees: Santen Pharmaceutical Co., Ltd.Inventors: Teruo Nishida, Makoto Inui, Masatsugu Nakamura
-
Publication number: 20100099629Abstract: An object is to find the minimum activity expression site of fibronectin, clarify the actions of this minimum unit in relation to opthalmological fields, and provide an opthalmological composition having this minimum unit as an effective component. This invention provides an opthalmological composition, in particular, a corneal disorder treatment agent containing the peptide, PHSRN (SEQ ID NO: 1) (Pro-His-Ser-Arg-Asn (SEQ ID NO: 1)), or Ac-Pro-His-Ser-Arg-Asn-NH2, which is a derivative thereof, or a salt thereof that is allowable as a medical drug as an effective component. The preferred dosage form is an ophthalmic formulation.Type: ApplicationFiled: September 15, 2009Publication date: April 22, 2010Applicant: Nihon Tenganyaku Kenkyusho Co., LTD.Inventors: Teruo NISHIDA, Yorihisa Uetake, Hiroaki Iwata
-
Publication number: 20090005317Abstract: A method for treating a corneal disorder or for promoting skin wound healing comprising administering to a patient in need thereof a composition containing pharmaceutically effective amounts of (i) a first peptide comprising an amino acid sequence containing the following consecutive amino acids: Ser-Ser-Ser-Arg (SEQ ID NO: 1), or an analog thereof or a pharmaceutically acceptable salt thereof and (ii) a second peptide comprising an amino acid sequence containing the following consecutive amino acids with a terminal —NH2 group: Phe-Gly-Leu-Met-NH2 (SEQ ID NO: 2), or an analog thereof or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.Type: ApplicationFiled: March 20, 2007Publication date: January 1, 2009Applicants: SANTEN PHARMACEUTICAL CO., LTD., Teruo NISHIDAInventors: Teruo Nishida, Makoto Inui, Masatsugu Nakamura
-
Patent number: 7232881Abstract: A peptide, wherein the peptide is selected from the group consisting of Ser-Ser-Ser-Arg (SEQ ID NO: 1), Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 4), Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 5), Gly-Ser-Ser-Ser-Arg (SEQ ID NO: 6), Gly-Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 7), Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 8), Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro (SEQ ID NO: 9) and Gly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro (SEQ ID NO: 10), or a pharmaceutically acceptable salt thereof.Type: GrantFiled: December 3, 2002Date of Patent: June 19, 2007Assignees: Santen Pharmaceutical Co., Ltd.Inventors: Teruo Nishida, Makoto Inui, Masatsugu Nakamura
-
Publication number: 20060234945Abstract: An object is to find the minimum activity expression site of fibronectin, clarify the actions of this minimum unit in relation to ophthalmological fields, and provide a ophthalmological composition having this minimum unit as an effective component. This invention provides an ophthalmological composition, in particular, a corneal disorder treatment agent containing the peptide, PHSRN (SEQ ID NO: 1)(Pro-His-Ser-Arg-Asn (SEQ ID NO: 1)), or Ac-Pro-His-Ser-Arg-Asn-NH2, which is a derivative thereof, or a salt thereof that is allowable as a medical drug as an effective component. The preferred dosage form is an ophthalmic formulation.Type: ApplicationFiled: December 24, 2003Publication date: October 19, 2006Applicant: Nihon Tenganyaku Kenkyusho Co., LTD.Inventors: Teruo Nishida, Yorihisa Uetake, Hiroaki Iwata
-
Patent number: 7071166Abstract: The present invention provides healing promoters for skin wounds such as rupture, abrasion, surgical incision, skin ulcer and burn. Coexistence of Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 (SEQ ID NO: 1) or Phe-Gly-Leu-Met-NH2 (SEQ ID NO: 2) with insulin-like growth factor-I exhibits a remarkable promotive action on healing the skin wounds. Accordingly, combined administration of at least one of the substance P analogs and pharmaceutically acceptable salts thereof with the insulin-like growth factor exhibits a promotive effect on epidermal extension and a promotive effect on healing the skin wounds.Type: GrantFiled: August 10, 2001Date of Patent: July 4, 2006Assignees: Santen Pharmacetical Co., Ltd.Inventors: Teruo Nishida, Katsuhiko Nakata, Masatsugu Nakamura
-
Publication number: 20060094775Abstract: The present invention provides a pharmaceutical agent capable of effectively treating corneal ulcer, more particularly, a therapeutic agent for corneal ulcer, which contains triptolide or a derivative thereof or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: February 27, 2004Publication date: May 4, 2006Inventors: Teruo Nishida, Yoshikuni Nakamura
-
Publication number: 20050009752Abstract: It is an object of the invention to examine the minimum unit of the exhibition of the activity of insulin-like growth factor-I and find a pharmaceutical use thereof in the fields of ophthalmology and dermatology. A joint administration of a peptide containing the amino acid sequence represented by Ser-Ser-Ser-Arg as the minimum unit of the exhibition of the activity of insulin-like growth factor-I and a peptide containing the amino acid sequence represented by Phe-Gly-Leu-Met-NH2 is effective for curing corneal disorders and can significantly promote the healing of skin wounds.Type: ApplicationFiled: December 3, 2002Publication date: January 13, 2005Inventors: Teruo Nishida, Makoto Inui, Masatsugu Nakamura